Skip to content

The detection of small intestine lesions and prevalence of celiac disease in patients with irritable bowel syndrome: a national multicenter, cross-sectional study

The detection of small intestine lesions and prevalence of celiac disease in patients with irritable bowel syndrome: a national multicenter, cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048980
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-07-30
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small intestine lesion and celiac disease

Interventions

case series:None

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years, gender is not limited; 2. Outpatient or inpatient patients who meet the Rome III diagnostic criteria for IBS; 3. No organic disease was found by routine tests such as blood test, gastroscope, colonoscopy, abdominal ultrasound (the results are valid within 1 year).

Exclusion criteria

Exclusion criteria: 1. History of previous gastrointestinal surgery, suspected incomplete gastrointestinal obstruction, intestinal adhesions, strictures, fistulas and other conditions that may cause intestinal obstruction; 2. Intestinal organic diseases such as inflammatory bowel disease, infectious bowel disease, and intestinal tumor (intestinal polyps <=5mm can still be added); 3. Hyperthyroidism, diabetes, myasthenia gravis and other systemic diseases that may affect the function of the gastrointestinal tract; 4. Those who need to take hormones, immunosuppressants, NSAIDs, anticoagulants and other drugs that the researchers think may affect the study for a long time and cannot stop the drugs; 5. Those who are pregnant or who cannot be used for effective contraception during the research period; 6. Those who are unable to cooperate with severe mental and psychological diseases or serious systemic diseases; 7. Those who have implanted cardiac pacemakers or other electronic devices; 8. Those who have no conditions for abdominal surgery or who refuse to accept abdominal surgery; 9. Patients who have difficulty swallowing and cannot swallow capsule endoscopy; 10. Patients who are judged by the investigator to be unsuitable to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
Detection rate of small intestine lesion;Seropositive rate of celiac disease antibody;Small bowel transit time for capsule endoscopy;

Secondary

MeasureTime frame
Genetic testing (HLA-DQ2 and/or HLA-DQ8) positive rate;

Countries

China

Contacts

Public ContactChen Minhu

The First Affiliated Hospital of Sun Yat-Sen University

chenminhu@mail.sysu.edu.cn+86 13802957089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026